Publicacións en colaboración con investigadores/as de Fox Chase Cancer Center (2)

2011

  1. Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase

    Cancer Research, Vol. 71, Núm. 3, pp. 675-685

2008

  1. Dosing strategies for MLN8054, a selective Aurora A kinase inhibitor, based on pharmacokinetic modeling and simulations

    EJC SUPPLEMENTS